Our findings showed that DKK1 promoted the migration and angiogenesis via up-regulating the angiogenesis-related molecules by activation of CKAP4/PI3K pathway, which indicated that anti-DKK1 therapy may prevent tumor and meanwhile reduce unstable plaques 37. Here, DKK1 is linked to neoplasm.